Figures (7)  Tables (5)

    • Figure 1. 

      Qualitative phytochemical screening for stem, bark, and needle extracts.

    • Figure 2. 

      Total phenolic content, Total flavonoids content, and Total tannin content of stem, bark, and needle extracts of T. wallichiana.

    • Figure 3. 

      Heatmap showing preliminary screening of antimicrobial potential (zone of inhibition (mm)) of needle, stem, and bark of T. wallichiana.

    • Figure 4. 

      Schematic diagram of selectivity triangle principle for mobile phase optimization

    • Figure 5. 

      (a) Schematic representation of different subfractions collected from fractionation of methanol and ethyl acetate fraction of T. wallichiana needle. (b) Antimicrobial activity of collected fractions of ethyl acetate extract through column chromatography.

    • Figure 6. 

      (a) Schematic diagram for finalizing the mobile phase for the TLC. (b) Schematic diagram for the TLC-Bioautography.

    • Figure 7. 

      (a) Heatmap showing antimicrobial potential (zone of inhibition (mm)) of final fraction and isolated compounds having antimicrobial activity. PA= palmitic acid, SA= stearic acid, AA= arachidic acid, MY = myoinositol, and HA = hexadecane, PA = procainamide, CN = cinchonine, NA = nicotinamide, TM = timolol. B1) B. megaterium, B2) B. Subtilis, B3) E. coli; and B4) S. marcescens. (A and F2) A. niger, B and C P. variotii, D) F. oxysporum E and F) T. hirsuta. B) FTIR spectra of rich fraction FA, FB, and FC of T. wallichiana needles.

    • Mobile phase I (%) Solvent strength Mobile phase II (%) Solvent strength Mobile phase III
      Hexane (100) − 0 E. Acetate (100) − 4.4 0.1 % acetic acid in methanol (5.1)
      Hexane (90) E. acetate (10) 0.44 E. acetate (90) Methanol (10) 4.47
      Hexane (80) E. acetate (20) 0.88 E. acetate (80) Methanol (20) 4.54
      Hexane (70) E. acetate (30) 1.32 E. acetate (70) Methanol (30) 4.61
      Hexane (60) E. acetate (40) 1.76 E. acetate (60) Methanol (40) 4.68
      Hexane (50) E. acetate (50) 2.2 E. acetate (50) Methanol (50) 4.75
      Hexane (40) E. acetate (60) 2.64 E. acetate (40) Methanol (60) 4.82
      Hexane (30) E. acetate (70) 3.08 E. acetate (30) Methanol (70) 4.89
      Hexane (20) E. acetate (80) 3.52 E. acetate (20) Methanol (80) 4.96
      Hexane (10) E. acetate (90) 3.96 E. acetate (10) Methanol (90) 5.03

      Table 1. 

      Solvent strength of mobile phase used for separation of compounds using column chromatography (CC)

    • Code Mobile Phase Ratio Solvent strength Separation Spot Rf value
      M1 Chloroform: E. acetate: formic acid (5:4:1) 4.4 Yes 2 0.6, 0.7
      M2 E. acetate: methanol: Benzene (2:0.5:2.5) 3.6 Yes 3 0.3, 0.6, 0.68
      M3 Ethanol: chloroform (1:1) 4.2 Yes 4 0.4, 0.56, 0.64, 0.83
      M4 Toluene: E. acetate: formic acid (6:4:0.5) 3.2 Yes 5 0.25, 0.38, 0.43, 0.64 and 0.81
      M5 Hexane: acetone: toluene: ethanol (10:7:7:6) 5.2 No No No
      M6 Chloroform: acetonitrile (7:3) 4.6 Yes 3 0.77, 0.8, 0.85
      M7 Chloroform: methanol (7: 1) 3.9 Yes 8 0.67, 0.15, 0.19, 0.32, 0.40, 0.45,0.62, 0.75
      M8 E. acetate: 2-propanol (95:5) 4.3 No No No
      M9 Chloroform: E. acetate: methanol (25:20:5) 4.3 Yes 5 0.25,0.4, 0.54, 0.68, 0.76
      M10 Chloroform: formic acid: acetonitrile (6:0.5:3.5) 3.3 No No No

      Table 2. 

      Solvent strength of mobile phase used for separation of compounds using thin layer chromatography (TLC)

    • Code Mobile Phase Ratio Solvent strength
      M 11 Hexane: E. acetate (7:3) 1.32
      M 12 Toluene: methanol (8:2) 2.94
      M 13 Methanol: chloroform (1:1) 4.6
      M 14 DMF: DCM: acetonitrile (5:1:4) 5.83
      M 15 Acetic acid: methanol: water (5:2.5:2.5) 6.77

      Table 3. 

      Solvent strength of mobile phase used for separation of compounds present in spot 2 through thin layer chromatography (TLC) and column chromatography (CC)

    • Fraction (FA) Compounds Fraction (FB) Compounds Fraction (FC) Compounds
      GC-MS
      1,6-Octadine-3-ol Benzoic acid Benzenepropanol
      Benzoic acid 4-Tetradecene Megastigmatrienone
      Benzene, 1-methoxy 4 - (2 - propenyl) 2,4-Ditert-butylphenol Ar-tumerone
      Phenol, 2-methyl-5-(1-methylethyl) 9-Octadecanoic acid Mome-inositol
      1-Tridecene Hexadecane Hexadecanoic acid
      Pentadecane 1,4-Dimethyl-2 phenoxybenzene 9-Octadecenoic acid
      Succinic acid E-15-Heptadecenal Eicosanoic acid
      E-14-Hexadecenal Benzene dicarboxylic acid Di-n-octyl phthalate
      Neophytadiene Hexadecanoic acid
      Hexadecanoic acid 1-Nonadecene
      1-Nonadecene Ecosanoic acid
      Docosanoic acid Octacosanol
      1- Tetradecanol Phenol, 2,4-bis(1-phenylethyl)
      Benzene dicarboxylic acid Di-n-octyl phthalate
      LC-MS
      1- aminocyclopropane-1- carbocyclic acid Nicotinamide Nicotinamide
      Methyl methanethiosulfonate Cinchonine Dodecylsulfonylacetic acid
      Methionyl-Glycin Ranitidine Diphenoxylic acid
      Ergothioneine Psoralenol Cinchonine
      Procainamide Squamocin B Ergothioneine
      Alcoifosfamide Trimethaphan
      Timolol Timolol
      Boviquinone Trimethaphan
      Lobaric acid Frangulanine

      Table 4. 

      A list of identified compounds in fractions showed antimicrobial activity

    • S. No. Compounds Formula Molar Mass Classification Concentration in needles mg/g (dw)
      GC-FID analysis
      1 Arachidic acid C20H40O2 312.53 g/mol Saturated fatty acid 22.94 ± 0.09
      2 Behenic acid C22H44O2 340.58 g/mol Saturated fatty acid 31.04 ± 0.05
      3 Palmitic acid C16H32O2 256.43 g/mol Saturated fatty acid 16.81 ± 0.03
      4 Stearic acid C18H36O2 284.48 g/mol Saturated fatty acid 20.10 ± 0.06
      RP-HPLC-PDA analysis
      5 Cinchonine C19H22N2O 294.17 g/mol Alkaloid 3.75 ± 1.21
      6 Nicotinamide C6H6N2O 122.12 g/mol Vitamin 21.14 ± 0.53
      7 Procainamide C13H21N3O 235.325 g/mol aminobenzamides 14.61 ± 0.71
      8 Timolol C13H24N4O3S 316.421 g/mol Alkaloid 6.31 ± 0.54
      9 Myoinositol C6H12O6 180.16 g/mol carbocyclic sugar 1.45 ± 1.01
      10 Hexadecane C16H34 226.41 g/mol alkane hydrocarbon −

      Table 5. 

      List of compounds identified in the separated fraction (spot 2) having antimicrobial potential